No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
10-Q: Q3 2024 Earnings Report
10-Q: Q2 2024 Earnings Report
10-Q: Q1 2024 Earnings Report
Bellevue Life Sciences Acquisitions Corp. Reminds Stockholders to Vote in Favor of Extension at May 14, 2024 Stockholder Meeting
OSR Holdings and SillaJen Have Entered Into a Memorandum of Understanding to Collaboratively Pursue the Development of Innovative Therapeutics and Enter the U.S. Market
SPAC Bellevue Life Sciences to Merge With South Korea's OSR